The University no longer operates any Biosafety Level 3 laboratories following changes to SARS-CoV-2 research containment ...

On May 25, 2023, merely six weeks before the Wuhan Biosafety lab lost its NIH funding amid the controversy of possible lab leaks and connection with COVID-19, the U.S. proudly opened the doors of the ...

A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...

In Manhattan, Kan., the National Bio and Agro-Defense Facility (NBAF), an animal disease research facility, has finished construction. Replacing the 68-year-old Plum Island Animal Disease Center, NBAF ...

The lowest of the four biosafety levels and is suitable for work involving well-characterized agents not known to consistently cause disease in healthy adult humans. These organisms pose minimal ...

BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...

A former senior adviser to National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci shared “confidential” communications with EcoHealth Alliance about how the agency was ...

Vanderbilt University Medical Center has been awarded a nearly $8 million grant to construct a facility for research involving COVID-19, anthrax, tuberculosis and other dangerous microorganisms. The ...

The two documents that apply broadly to biological agents and research in the United States are Biosafety in Microbiological and Biomedical Laboratories and National Institutes of Health Guidelines ...

The debate on whether to regulate the types of biosafety levels permitted in labs in San Carlos was meant to be put to an end Monday but councilmembers agreed to postpone their vote until all five ...

The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids (NIH Guidelines) provide details regarding "the practices for constructing and handling: (i) recombinant nucleic acid ...